Fidia S.p.A. (FDA.MI)
- Previous Close
0.4800 - Open
0.4930 - Bid 0.4790 x --
- Ask 0.4890 x --
- Day's Range
0.4780 - 0.4970 - 52 Week Range
0.2650 - 1.4700 - Volume
203,854 - Avg. Volume
369,334 - Market Cap (intraday)
15.111M - Beta (5Y Monthly) 0.17
- PE Ratio (TTM)
-- - EPS (TTM)
-0.1900 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date Jul 3, 2017
- 1y Target Est
--
Fidia S.p.A., together with its subsidiaries, designs, manufactures, and sells high speed milling systems, numerical controls, milling heads, and software systems. Its accessories comprise HMS, a device for measuring and compensating geometric error on continuous or indexed bi-rotary heads and roto-tilting tables; TMSC, a device to measure length and diameter of the tool, as well as to check the shape; K5 tracer, a solution to perform continuous scanning of 3D surfaces; pushbutton panels; XPower digital drives for axis and spindle movement; and I/O Line input/output modules. The company's software solutions include ViMill, an anti-collision solution; Machine Monitor, a software to monitor NC variables and parameters; Velocity 6, a solution for axes control to enhance the performances of the machine; HiMill, a CAM software for the machining of dies, models, and aeronautical components; Isograph solution, a user interface; and procedure-PRX, a solution for customized automation. It serves automotive, aerospace, and power generation industries in Italy, Europe, Asia, North and South America, and internationally. The company was founded in 1974 and is headquartered in San Mauro Torinese, Italy.
www.fidia.itRelated News
Performance Overview: FDA.MI
Trailing total returns as of 4/23/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: FDA.MI
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: FDA.MI
Valuation Measures
Market Cap
15.11M
Enterprise Value
23.38M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.12
Price/Book (mrq)
4.70
Enterprise Value/Revenue
0.82
Enterprise Value/EBITDA
-63.72
Financial Highlights
Profitability and Income Statement
Profit Margin
-19.39%
Return on Assets (ttm)
--
Return on Equity (ttm)
--
Revenue (ttm)
24.22M
Net Income Avi to Common (ttm)
-4.7M
Diluted EPS (ttm)
-0.1900
Balance Sheet and Cash Flow
Total Cash (mrq)
8.34M
Total Debt/Equity (mrq)
426.13%
Levered Free Cash Flow (ttm)
--
Research Analysis: FDA.MI
Company Insights: FDA.MI
FDA.MI does not have Company Insights